article · Heliyon
4-Acetylpyridine <b>1</b> and malononitrile <b>2</b> were allowed to react in a 3MCRs with dimedone <b>3a</b> or cyclohexa-1,3-dione <b>3b</b> under reflux to afford 4-methyl-4-(pyridin-4-yl)-5,6,7,8-tetrahydro-4<i>H</i>-chromene derivatives <b>4a,b</b> respectively. The mechanism of the reaction has been studied and the structures elucidated by analytical, spectral as well as X-ray crystallographic data. Heterocyclic compounds find widespread application in pharmaceutical and agrochemical products. Docking analyses were performed on the synthesized compounds to assess their binding modes with various amino acids of the target protein tubulin (PDB Code - 1SA0). The results indicated promising binding scores for compounds <b>4a</b> and <b>4b</b>, suggesting a strong affinity for the tubulin binding site. Finally, ADMET for the synthesized compounds <b>4a, 4b, 5, 8a</b> and <b>8b</b> were carried out. The drug likeness and pharmacokinetic properties of the prepared compounds were also evaluated. Notably, all of the novel compounds adhered to Lipinski's rule (Ro5) without any violations.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.heliyon.2024.e29221
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.